Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 4
1978 2
1979 6
1980 4
1981 6
1982 4
1983 3
1984 5
1985 9
1986 6
1987 9
1988 11
1989 19
1990 18
1991 27
1992 9
1993 25
1994 24
1995 26
1996 24
1997 25
1998 21
1999 41
2000 33
2001 50
2002 35
2003 45
2004 69
2005 48
2006 55
2007 80
2008 63
2009 89
2010 83
2011 84
2012 82
2013 105
2014 136
2015 128
2016 129
2017 158
2018 154
2019 174
2020 197
2021 237
2022 203
2023 176
2024 80

Text availability

Article attribute

Article type

Publication date

Search Results

2,683 results

Results by year

Filters applied: . Clear all
Page 1
Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults.
Langelier C, Kalantar KL, Moazed F, Wilson MR, Crawford ED, Deiss T, Belzer A, Bolourchi S, Caldera S, Fung M, Jauregui A, Malcolm K, Lyden A, Khan L, Vessel K, Quan J, Zinter M, Chiu CY, Chow ED, Wilson J, Miller S, Matthay MA, Pollard KS, Christenson S, Calfee CS, DeRisi JL. Langelier C, et al. Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12353-E12362. doi: 10.1073/pnas.1809700115. Epub 2018 Nov 27. Proc Natl Acad Sci U S A. 2018. PMID: 30482864 Free PMC article.
When tested in the validation cohort, the pathogen metric performed with an area under the receiver-operating curve (AUC) of 0.96 (95% CI, 0.86-1.00), the diversity metric with an AUC of 0.80 (95% CI, 0.63-0.98), and the host transcriptional classifier with an AUC of 0.88 (95% CI …
When tested in the validation cohort, the pathogen metric performed with an area under the receiver-operating curve (AUC) of 0.96 (95% CI, 0 …
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
Kwon O, Senna MM, Sinclair R, Ito T, Dutronc Y, Lin CY, Yu G, Chiasserini C, McCollam J, Wu WS, King B. Kwon O, et al. Am J Clin Dermatol. 2023 May;24(3):443-451. doi: 10.1007/s40257-023-00764-w. Epub 2023 Mar 1. Am J Clin Dermatol. 2023. PMID: 36855020 Free PMC article. Clinical Trial.
Of patients treated with baricitinib 4 mg and 2 mg, respectively, 40.9% and 21.2% in BRAVE-AA1 and 36.8% and 24.4% in BRAVE-AA2 achieved a SALT score 20 at Week 52. The most frequent treatment-emergent adverse events included upper respiratory tract infect …
Of patients treated with baricitinib 4 mg and 2 mg, respectively, 40.9% and 21.2% in BRAVE-AA1 and 36.8% and 24.4% in BRAVE-AA2 achieved a S …
Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb.
Wollenberg A, Howell MD, Guttman-Yassky E, Silverberg JI, Kell C, Ranade K, Moate R, van der Merwe R. Wollenberg A, et al. J Allergy Clin Immunol. 2019 Jan;143(1):135-141. doi: 10.1016/j.jaci.2018.05.029. Epub 2018 Jun 12. J Allergy Clin Immunol. 2019. PMID: 29906525 Free article. Clinical Trial.
Coprimary end points were change from baseline in Eczema Area Severity Index score and percentage of participants with an Investigator's Global Assessment response (0/1 score and reduction of 2 grades from baseline) at week 12. ...Participants treated with 300 mg of …
Coprimary end points were change from baseline in Eczema Area Severity Index score and percentage of participants with an Investigato …
Sputum pathogen spectrum and clinical outcomes of upper respiratory tract infection in bronchiectasis exacerbation: a prospective cohort study.
Huang Y, Chen CL, Cen LJ, Li HM, Lin ZH, Zhu SY, Duan CY, Zhang RL, Pan CX, Zhang XF, Zhang XX, He ZF, Shi MX, Zhong NS, Guan WJ. Huang Y, et al. Emerg Microbes Infect. 2023 Dec;12(1):2202277. doi: 10.1080/22221751.2023.2202277. Emerg Microbes Infect. 2023. PMID: 37038356 Free PMC article.
Upper respiratory tract infection (URTI) is common in humans. We sought to profile sputum pathogen spectrum and impact of URTI on acute exacerbation of bronchiectasis (AE). ...Having experienced URTI-AE predicted a greater risk of future URTI-AE (OR: 1 …
Upper respiratory tract infection (URTI) is common in humans. We sought to profile sputum pathogen spectrum and impact …
Respiratory Conditions: Lower Respiratory Tract Infections.
Mahowald M, Shahan B, Forbes D. Mahowald M, et al. FP Essent. 2019 Nov;486:19-25. FP Essent. 2019. PMID: 31710454
Acute bronchitis and pneumonia are conditions commonly diagnosed in inpatient and outpatient settings. Acute bronchitis is a lower respiratory tract infection characterized by cough, with or without sputum production, lasting 1 to 3 weeks. ...Ultrasonography …
Acute bronchitis and pneumonia are conditions commonly diagnosed in inpatient and outpatient settings. Acute bronchitis is a lower respir …
Pathogenesis of Middle East respiratory syndrome coronavirus.
van den Brand JM, Smits SL, Haagmans BL. van den Brand JM, et al. J Pathol. 2015 Jan;235(2):175-84. doi: 10.1002/path.4458. J Pathol. 2015. PMID: 25294366 Free PMC article. Review.
Zoonotic transmission of CoVs such as the recently identified Middle East respiratory syndrome (MERS)-CoV and severe acute respiratory syndrome (SARS)-CoV, on the other hand, may be associated with severe lower respiratory tract infection. This article review …
Zoonotic transmission of CoVs such as the recently identified Middle East respiratory syndrome (MERS)-CoV and severe acute respiratory syndr …
Respiratory tract infection and risk of bleeding in oral anticoagulant users: self-controlled case series.
Ahmed H, Whitaker H, Farewell D, Hippisley-Cox J, Noble S. Ahmed H, et al. BMJ. 2021 Dec 21;375:e068037. doi: 10.1136/bmj-2021-068037. BMJ. 2021. PMID: 34933893 Free PMC article.
MAIN OUTCOME MEASURES: Relative incidence of major bleeding and clinically relevant non-major bleeding in the 0-14 days after an untreated respiratory tract infection, compared to unexposed time periods. RESULTS: Of 1208 study participants, 58% (n=701) were m …
MAIN OUTCOME MEASURES: Relative incidence of major bleeding and clinically relevant non-major bleeding in the 0-14 days after an untreated …
Risk factors for recurrent respiratory tract infection in preschool-aged children.
Zhou B, Niu W, Liu F, Yuan Y, Wang K, Zhang J, Wang Y, Zhang Z. Zhou B, et al. Pediatr Res. 2021 Jul;90(1):223-231. doi: 10.1038/s41390-020-01233-4. Epub 2020 Nov 10. Pediatr Res. 2021. PMID: 33173178
BACKGROUND: We aimed to identify potential risk factors for recurrent respiratory tract infection among Chinese preschool-aged children, and further to construct a nomogram prediction model. ...Besides the leading role played by asthma, allergy, initia …
BACKGROUND: We aimed to identify potential risk factors for recurrent respiratory tract infection among Chinese prescho …
Deconstruction of Clinical Treatment of Pneumonia and Respiratory Tract Infection Based on MRI Molecular Imaging.
Jiang L, Shen Y, Yu Z, Xu W. Jiang L, et al. Contrast Media Mol Imaging. 2022 Sep 26;2022:7146978. doi: 10.1155/2022/7146978. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 36237582 Free PMC article. Retracted. Clinical Trial.
Pneumonia is a major research core topic in the medical field, and clinical trials of pneumonia and respiratory tract infection have been ongoing. The purpose of this study was to investigate the clinical efficacy and safety of Shuanghuanghua granules in the …
Pneumonia is a major research core topic in the medical field, and clinical trials of pneumonia and respiratory tract infec …
Diagnosis, admission, discharge.
Everard M. Everard M. Paediatr Respir Rev. 2009 Jun;10 Suppl 1:18-20. doi: 10.1016/S1526-0542(09)70009-0. Paediatr Respir Rev. 2009. PMID: 19651395 Review.
The respiratory syncytial virus should be considered as the most likely pathogen in an infant or young child with a significant acute lower respiratory tract infection during the characteristic epidemic season. ...Social factors may further influence the like …
The respiratory syncytial virus should be considered as the most likely pathogen in an infant or young child with a significant acute lower …
2,683 results